KEWAUNEE SCIENTIFIC CORP /DE/ Financials
Quarterly XBRL submissions from SEC 10-K and 10-Q filings.
Income Statement (Last 8 Quarters)
(3)| Period | Revenue | YoY % | Net Income | YoY % | Operating Income | EPS |
|---|---|---|---|---|---|---|
| Q2 FY202610-Q · 2025-10-31 | $70.1M | — | $2.4M | — | $4.1M | $0.82 |
| Q1 FY202610-Q · 2025-07-31 | $16.8M | — | $4.7M | — | $4.8M | $1.04 |
| Q3 FY202510-Q · 2025-01-31 | $67.2M | — | $1.4M | — | $2.3M | $0.45 |
Balance Sheet
| Period | Total Assets | Total Liabilities | Cash & Equivalents | Shareholders Equity |
|---|---|---|---|---|
| Q2 FY202610-Q | $189.1M | $117.4M | $12.6M | $69.9M |
| Q1 FY202610-Q | $193.5M | $124.6M | $19.5M | -$4.2M |
| Q3 FY202510-Q | $189.1M | $127.0M | $9.5M | -$3.8M |
Cash Flow Highlights
| Period | Operating Income | Net Income | Gross Profit | Shares Outstanding |
|---|---|---|---|---|
| Q2 FY202610-Q | $4.1M | $2.4M | $19.7M | 2,866,000 |
| Q1 FY202610-Q | $4.8M | $4.7M | $20.9M | 2,865,000 |
| Q3 FY202510-Q | $2.3M | $1.4M | $18.4M | 2,872,000 |
Filings
(4)Methodology
Every figure on this page is pulled directly from KEWAUNEE SCIENTIFIC CORP /DE/'s own XBRL submissions to the U.S. Securities and Exchange Commission. XBRL is the standardized tagging format the SEC requires for line items in 10-K and 10-Q filings, which means revenue, net income, and balance-sheet entries are reported by the company itself — not estimated by us.
Cayman Journal reconciles preferred GAAP tags (for example, Revenues, RevenueFromContractWithCustomerExcludingAssessedTax) and normalizes them so quarter-over-quarter comparability is preserved. Our automated ingestion runs nightly; markets editors spot-check flagged anomalies before they appear on the public hub. Where a tag is missing for a given period, we surface an em dash rather than impute a value.
Source documents are linked under Filings above and point to the original EDGAR submission index. Errors should be reported to [email protected].